Technology

X4 Pharmaceuticals

$8.49
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.17 (+2.04%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell XFOR and other stocks, options, and ETFs commission-free!

About XFOR

X4 Pharmaceuticals, Inc. operates as a biotechnology company, which engages in developing human antibodies for treating infectious diseases. The company focuses on restoring healthy immune system function by developing novel therapeutics for the treatment of rare diseases. Its products in pipeline include X4P-001, X4P-002, and X4P-003. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan and is headquartered in Cambridge, MA. The listed name for XFOR is X4 Pharmaceuticals, Inc. Common Stock.

CEO
Paula S. Ragan
Employees
58
Headquarters
Cambridge, Massachusetts
Founded
2010
Market Cap
138.77M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
92.68K
High Today
$8.85
Low Today
$8.07
Open Price
$8.29
Volume
113.87K
52 Week High
$11.11
52 Week Low
$5.38

Collections

XFOR Earnings

-$0.87
-$0.58
-$0.29
-$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 11, Pre-Market

You May Also Like

GCC
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure